Bloomage Biotechnology Corp Ltd (688363) — Working Capital to Net Assets Ratio
Bloomage Biotechnology Corp Ltd (688363) has a Working Capital to Net Assets ratio of 23.0% as of March 2026. Working capital of CN¥1.65 Billion (current assets of CN¥2.86 Billion minus current liabilities of CN¥1.21 Billion) is measured against net assets of CN¥7.16 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Bloomage Biotechnology Corp Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bloomage Biotechnology Corp Ltd Working Capital to Net Assets (2012–2025)
This chart shows how Bloomage Biotechnology Corp Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 23.0%, reflecting working capital of CN¥1.65 Billion against net assets of CN¥7.16 Billion CNY. Check Bloomage Biotechnology Corp Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bloomage Biotechnology Corp Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Bloomage Biotechnology Corp Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 22.4% | CN¥1.59 Billion | CN¥7.12 Billion | CN¥2.78 Billion | CN¥1.19 Billion | ▲ +2.0 pp |
| 2024 | 20.5% | CN¥1.40 Billion | CN¥6.84 Billion | CN¥2.74 Billion | CN¥1.34 Billion | ▼ -6.8 pp |
| 2023 | 27.2% | CN¥1.90 Billion | CN¥6.98 Billion | CN¥3.12 Billion | CN¥1.22 Billion | ▼ -8.4 pp |
| 2022 | 35.6% | CN¥2.38 Billion | CN¥6.68 Billion | CN¥4.02 Billion | CN¥1.64 Billion | ▼ -9.7 pp |
| 2021 | 45.3% | CN¥2.58 Billion | CN¥5.70 Billion | CN¥3.98 Billion | CN¥1.40 Billion | ▼ -15.4 pp |
| 2020 | 60.7% | CN¥3.09 Billion | CN¥5.09 Billion | CN¥3.66 Billion | CN¥571.24 Million | ▼ -14.1 pp |
| 2019 | 74.8% | CN¥3.40 Billion | CN¥4.55 Billion | CN¥3.77 Billion | CN¥368.86 Million | ▲ +16.2 pp |
| 2018 | 58.6% | CN¥1.01 Billion | CN¥1.72 Billion | CN¥1.30 Billion | CN¥291.38 Million | ▼ -1.8 pp |
| 2017 | 60.3% | CN¥987.94 Million | CN¥1.64 Billion | CN¥1.17 Billion | CN¥181.82 Million | ▲ +12.9 pp |
| 2016 | 47.5% | CN¥598.33 Million | CN¥1.26 Billion | CN¥981.31 Million | CN¥382.98 Million | ▼ -7.2 pp |
| 2015 | 54.7% | CN¥651.42 Million | CN¥1.19 Billion | CN¥1.28 Billion | CN¥624.10 Million | ▲ +7.4 pp |
| 2014 | 47.3% | CN¥355.74 Million | CN¥752.51 Million | CN¥516.40 Million | CN¥160.65 Million | ▼ -7.5 pp |
| 2013 | 54.8% | CN¥309.34 Million | CN¥564.35 Million | CN¥431.98 Million | CN¥122.64 Million | ▼ -1.1 pp |
| 2012 | 55.9% | CN¥210.62 Million | CN¥376.97 Million | CN¥259.29 Million | CN¥48.67 Million | — |